This week landed heavily on prediction models, which is a pattern worth naming: we have ten studies building or validating machine learning systems across maternal outcomes, fertility, and postpartum mental health.
The strongest thread is early warning systems that actually move the needle on timing, cardiotocography models catching fetal hypoxia three to six hours earlier than standard care, and time-aware approaches outperforming last-minute alerts. That's actionable. But here's what I'm watching: four preprints, and none of them peer-reviewed yet, which means we should hold tight on claims until those pass review. More important, nearly everything assumes you have clean data and access to the technology. The lactation study and the piece on PMOS treatment gaps in rural India both name what we don't have: lactation status isn't even recorded in administrative data, and whole regions lack access to basic care. Before we celebrate the next algorithm, I want to know who gets left out when it deploys. I'd suggest leading with the early warning timing story, it's concrete, and holding a second post on the evidence gaps the models expose.
Notice Not medical advice. Summaries are machine-written from each source's own text and can be wrong; check the original before citing. House rules
Wells’s top five
I Global Excess Maternal Mortality During the COVID-19 Pandemic: Country-Level Counterfactual Estimates and Associated Factors
This study estimates 68,489 excess maternal deaths globally during 2020-2023 using counterfactual modeling, finding statistically detectable excess in 113 countries but showing that broad disruption measures alone do not explain deviations in maternal mortality ratios.
TrotamedRxiv, published Mon, Sep 28Rated 5 of 5
II Predicting Endometriosis Status and Menstrual Cycle Phase Using DNA Methylation
This preprint develops a machine learning pipeline using DNA methylation from ~759,000 CpG sites to classify endometriosis and menstrual cycle phase, achieving strong performance (AUROC 0.989 for cycle phase, 0.875 for endometriosis).
TrotabioRxiv : the preprint server for biology, published 2026Rated 5 of 5
III Fast Track to Fertility
Fast Track to Fertility trial completed, testing an algorithmic text messaging platform (digital health/femtech) to support infertility patients.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 5 of 5
IV Creating VIP Corps to Reduce Maternal Deaths
Completed implementation trial of VIP Corps training (behavioral intervention) to reduce maternal mortality and morbidity, addressing structural gaps in maternal care.
ElionClinicalTrials.gov, published Mon, Oct 5Rated 5 of 5
V Digital menstrual tracking risks creating more harm than benefit, argue experts
Experts argue that digital menstrual tracking risks creating more harm than benefit.
LamarrMedical Xpress, published Wed, Sep 30Rated 5 of 5
From the desks
Trota
I found a strong week. The machine learning endometriosis model and the IVF live birth prediction study are both the kind of careful multicenter validation work worth following, though neither breaks new ground clinically yet. The postpartum weight loss RCT (Supporting MumS) looks solid on its face but is still preprint, so hold judgment until peer review. The postpartum depression biomarker paper is intriguing but early, with that remarkably high accuracy figure you'll want to read skeptically. For breadth, the evidence summary on digital tools for postpartum depression screening gives us a clean synthesis to build from. Nothing failed this week, but four items are preprint only, so flag those as provisional.
Global Excess Maternal Mortality During the COVID-19 Pandemic: Country-Level Counterfactual Estimates and Associated Factors
This study estimates 68,489 excess maternal deaths globally during 2020-2023 using counterfactual modeling, finding statistically detectable excess in 113 countries but showing that broad disruption measures alone do not explain deviations in maternal mortality ratios.
TrotamedRxiv, published Mon, Sep 28Rated 5 of 5
Predicting Endometriosis Status and Menstrual Cycle Phase Using DNA Methylation
This preprint develops a machine learning pipeline using DNA methylation from ~759,000 CpG sites to classify endometriosis and menstrual cycle phase, achieving strong performance (AUROC 0.989 for cycle phase, 0.875 for endometriosis).
TrotabioRxiv : the preprint server for biology, published 2026Rated 5 of 5
Iron homeostasis and endometriosis risk: Genetic evidence for a shared biological link
This genetic study identifies 8 shared genome-wide significant loci between endometriosis and iron homeostasis biomarkers, finding evidence that reduced systemic iron status is associated with increased endometriosis risk but with inconsistent evidence for causal bidirectional effects.
TrotamedRxiv, published Tue, Sep 29Rated 5 of 5
Predicting of early miscarriage based on machine learning: a retrospective cohort study in China
This retrospective cohort of 17,926 pregnancies (1,918 miscarriages) from China applied ten machine learning algorithms to serum hormone biomarkers (β-hCG, progesterone, estradiol) across gestational weeks to predict early miscarriage, comparing univariate and multivariate models to identify optimal timing and biomarkers.
TrotaBMC pregnancy and childbirth, published 2026Rated 5 of 5
The inverted pyramid of care in modern-day obstetrics
Policy Forum advocates for risk-stratified antenatal care pathways built around early prediction, prevention, and personalized surveillance, updating the 2011 'inverted pyramid of care' concept.
TrotaPLoS medicine, published 2026Rated 5 of 5
Show all 45 of her finds
Time-aware machine learning enables early intrapartum identification of fetuses at risk of hypoxic-ischemic encephalopathy from cardiotocography
Time-aware machine learning model trained on cardiotocography (CTG) data across full labor duration identified fetuses at risk of hypoxic-ischemic encephalopathy (HIE) 3–6 hours earlier than traditional last-hour-only models.
TrotamedRxiv, published Thu, Oct 1Rated 5 of 5
Integrating Artificial Intelligence into Reproductive Medicine: A Predictive Algorithm for Noninvasive Live Birth Assessment
Machine learning (XGBoost) model integrating morphokinetic, clinical, and semen variables predicted live birth after IVF with AUC 0.927, identifying transfer embryo class, second polar body timing, AMH, age, and BMI as top predictors.
TrotaJBRA assisted reproduction, published 2026Rated 5 of 5
Artificial Intelligence and Machine Learning for predicting Major Obstetric Emergencies: Current Evidence, Clinical Translation, and Future Directions
Narrative review synthesized evidence on AI/ML models (random forest, neural networks, XGBoost) for predicting postpartum hemorrhage, preeclampsia, and preterm birth; models showed promise but substantial heterogeneity in design, validation, and clinical implementation.
TrotaInternational journal of women's health, published 2026Rated 5 of 5
Foundation model-powered deep learning of endometrial histology for predicting the cumulative live birth of an in vitro fertilization cycle
A deep learning study using foundation models (UNI2-h) to predict cumulative live birth outcomes from endometrial histology images in IVF cycles, comparing end-to-end ResNet approaches with foundation model pipelines.
TrotaPLOS digital health, published 2026Rated 5 of 5
Clinical feature grouping-based FT-Transformer for postpartum depression risk prediction: a longitudinal cohort study in perinatal women
Develops a Clinical-Group Feature Tokenizer + Transformer (FT-Transformer) model for postpartum depression risk prediction using clinical feature grouping, achieving F1 score of 0.734 on internal testing.
TrotaPsychiatry research, published 2026Rated 5 of 5
Development and external validation of an explainable XGBoost model with a web-based calculator for risk prediction of postpartum depressive symptoms
Develops and externally validates an explainable XGBoost model with an accompanying web-based calculator for postpartum depressive symptom risk prediction using demographic, psychosocial, and obstetric variables from 553 women.
TrotaFrontiers in psychiatry, published 2026Rated 5 of 5
Closing Treatment Gaps for Polyendocrine Metabolic Ovarian Syndrome in India
A news piece on polycystic ovarian syndrome (PMOS), an understudied and underfunded condition, reporting on treatment gaps in India, especially rural regions, and a new digital twin treatment initiative.
TrotaJournal of medical Internet research, published 2026Rated 5 of 5
No Field for Lactation: Inferring Lactation Status From US Commercial Claims to Describe Postpartum Medication Dispensing
A preprint describing a claims-based phenotype to infer lactation status from U.S.
TrotamedRxiv, published Tue, Sep 29Rated 5 of 5
Robust forecasting of sedentary bouts in chronic pelvic pain disorders for on-device learning and real-time deployment
A privacy-preserving framework for real-time forecasting of sedentary bouts in 134 women with chronic pelvic pain using Fitbit data and on-device machine learning.
Trotanpj women's health, published 2026Rated 5 of 5
The relative importance of neighborhood environment features in explaining preeclampsia risk using machine learning
Machine learning with explainable AI (XGBoost) identified relative importance of neighborhood environment features, obesity prevalence, blood pressure prevalence, and short sleep duration, in explaining preeclampsia risk among 18,754 Philadelphia residents, enabling prioritization of community interventions.
TrotaPregnancy (Hoboken, N.J.), published 2026Rated 5 of 5
Environmental Chemicals as Modifiers of the Association between Age and Ovarian Reserve
A prospective cohort study of 775 women used machine learning (doubly robust learner) to identify endocrine-disrupting chemicals that modify the age-related decline in antral follicle counts, a marker of ovarian reserve.
TrotamedRxiv, published Mon, Oct 5Rated 5 of 5
Factors associated with prior pregnancy loss among multigravid women: a retrospective machine learning analysis from an African population cohort
A retrospective machine learning analysis of 655 multigravid women from Uganda applied multiple ML classifiers (Random Forest highest performance: MCC 0.36, ROC-AUC 0.7) to identify factors associated with pregnancy loss, highlighting candidate predictors for validation in African populations.
TrotaFrontiers in global women's health, published 2026Rated 5 of 5
Beyond Binary Diagnosis: A Genetic Algorithm Optimized Hybrid Machine Learning Model for PCOS Phenotype Prediction
Researchers developed a multi-task neural network optimized by genetic algorithm to predict PCOS phenotypes while maintaining binary classification accuracy, showing improved recall for underrepresented phenotype B (87.5%) and unclassified cases (79.6%) compared to single-task models.
TrotamedRxiv, published Mon, Oct 5Rated 5 of 5
A Machine Learning-Based Prediction Model for Deep Infiltrating Endometriosis
Study developed and internally validated a machine learning model (Random Forest outperformed GBM and SVM) for predicting deep infiltrating endometriosis using clinical, imaging, and lab data from 250 surgically confirmed cases.
TrotaInternational journal of women's health, published 2026Rated 5 of 5
A mobile app compared with an educational pamphlet on menopause hormone therapy initiation: a randomized pilot study
Randomized pilot study comparing a digital menopause symptom assessment tool (emmii app) with an educational pamphlet among 653 women aged 45-55 with MRS score ≥5.
TrotaFrontiers in reproductive health, published 2026Rated 5 of 5
Development and external validation of a three-stage model to predict live birth after fresh IVF/ICSI embryo transfer
A multicenter study developed and validated a three-stage sequential machine learning model to predict live birth after fresh IVF/ICSI, integrating data from baseline, ovarian stimulation, and embryo transfer stages.
TrotaFrontiers in endocrinology, published 2026Rated 5 of 5
Effectiveness of an automated text message intervention for weight management in postpartum women with overweight or obesity (Supporting MumS (SMS)): a UK wide, multicentre, two arm, parallel group, randomised controlled trial
Supporting MumS (SMS) is a UK multicentre RCT (n=892) testing whether fully automated text messaging with behaviour change techniques reduces weight in postpartum women with overweight/obesity over 12 months, with an active control comparing child health messaging.
TrotamedRxiv, published Tue, Oct 6Rated 5 of 5
Summary of current evidence for digital health interventions in the screening and management of postpartum depression
This evidence summary synthesizes current evidence on digital health strategies for postpartum depression screening and management using the 6S evidence hierarchy, reviewing 16 publications (2 guidelines, 13 systematic reviews) through May 2026 to develop practice-oriented recommendations for clinical nursing.
TrotaFrontiers in psychiatry, published 2026Rated 5 of 5
Late-pregnancy immune and kynurenine signatures predict postpartum depression and brain morphology
A prospective study (n=140) in pregnant women identifying third-trimester cytokine and kynurenine pathway metabolite signatures predictive of postpartum depression, with prediction accuracy of 93.3% when combined; associates biomarkers with postpartum grey matter volume in a neuroimaging subsample.
TrotamedRxiv, published Tue, Oct 6Rated 5 of 5
Blood transcriptomic signature associated with hypertension in females across two human cohorts
This multi-cohort transcriptomic study identifies a female-specific hypertension signature in blood driven by ETS family transcription factors, showing sex-by-hypertension interaction absent in males and correlation with pro-inflammatory signatures in arterial and kidney tissues in women.
TrotamedRxiv, published Mon, Sep 28Rated 4 of 5
Wearable biosensors characterize Baguazhang exercise intensity, trunk acceleration, and cardiovascular autonomic adaptations in postmenopausal women
This RCT used chest-strap ECG and waist-mounted tri-axial accelerometry to quantify cardiovascular intensity and trunk acceleration during Baguazhang exercise in 46 sedentary postmenopausal women over 12 weeks, measuring systolic blood pressure, diastolic blood pressure, and autonomic adaptation (LnRMSSD).
TrotaFrontiers in physiology, published 2026Rated 4 of 5
Early Pregnancy Glycosylated Hemoglobin in Relation to Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Evidence from a Multisite Low- and Middle-Income Countries Cohort
This multisite cohort study across Kenya, India, Pakistan, and Zambia evaluates whether early pregnancy HbA1c predicts gestational diabetes and adverse perinatal outcomes (hypertensive disorder, preterm birth, stillbirth, etc.), addressing implementation challenges of the OGTT gold standard in low- and middle-income settings.
TrotamedRxiv, published Tue, Sep 29Rated 4 of 5
"Whenever a girl has a problem, we all go to the bathroom together": Exploring Menstrual Health Care Ecosystems Through the Lived Experiences of Children and Adolescents
This HCI conference paper explores menstrual health care ecosystems through lived experiences of children and adolescents, with a quote illustrating how young people collectively navigate menstrual management in school settings.
TrotaAdjunct Proceedings of the 14th Nordic Conference on Human-Computer Interaction, published Wed, Sep 30Rated 4 of 5
Feminist Fabulations for Reworlding Menopause Care
A conference paper on feminist fabulations for reworlding menopause care, presented at a major HCI venue.
TrotaAdjunct Proceedings of the 14th Nordic Conference on Human-Computer Interaction, published Wed, Sep 30Rated 4 of 5
PFAS and phthalates in follicular fluid of a Nebraska in vitro fertilization (IVF) cohort
A preprint characterizing PFAS and phthalate metabolites in follicular fluid from women undergoing IVF in Nebraska, linking exposure data with demographics and clinical characteristics.
TrotamedRxiv, published Tue, Sep 29Rated 4 of 5
Uncovering Placental Endocrine Dysregulation in Gestational Diabetes Mellitus Using Bioinformatics and Machine Learning
A journal article using bioinformatics and machine learning (SVM-RFE and Boruta algorithms) to identify endocrine-related differentially expressed genes in gestational diabetes mellitus placental samples.
TrotaAmerican journal of reproductive immunology (New York, N.Y. : 1989), published 2026Rated 4 of 5
Endometriosis and Cardiovascular Disease Across Levels of Systemic Inflammation: A Cross-Sectional Study of NHANES 1999-2006
A cross-sectional study of 5,345 women aged 20-54 from NHANES (1999-2006) examining the association between endometriosis and early-onset CVD, stratified by systemic inflammation markers (CRP and SII).
TrotamedRxiv, published Wed, Sep 30Rated 4 of 5
Effect of air pollution on clinical pregnancy outcomes following intrauterine insemination: a machine learning-based analysis
A machine learning-based study analyzing 2,328 IUI cycles to investigate the association between air pollution exposure and clinical pregnancy outcomes.
TrotaFrontiers in public health, published 2026Rated 4 of 5
Early maternal plasma protein signatures identify preeclampsia risk in twin pregnancies
A nested case-control study of 84 women with twin pregnancies using mass spectrometry to profile maternal plasma proteins preceding preeclampsia.
TrotamedRxiv, published Wed, Sep 30Rated 4 of 5
Digital health innovations: imagining opportunities to support people with a learning disability experiencing menopause
A commentary on digital health innovations, fitness trackers, and wearable devices for supporting people with a learning disability experiencing menopause.
TrotaPost reproductive health, published 2026Rated 4 of 5
Mixed-Effects Machine Learning improved prediction of Obstetric Anal Sphincter Injury: a nationwide multicenter cohort study
Machine learning models using mixed-effects gradient boosting outperformed traditional regression in predicting obstetric anal sphincter injury (OASIS) in a nationwide Dutch cohort of 614,255 vaginal deliveries.
TrotamedRxiv, published Thu, Oct 1Rated 4 of 5
Standardized Reporting in Gynecological Ultrasonography in India: The Need of the Hour
This editorial advocates for standardized reporting frameworks in gynecological ultrasonography (O-RADS, IOTA, ADNEX, MUSA) and highlights how standardization could facilitate AI-based tool development.
TrotaCureus, published 2026Rated 4 of 5
A modified Delphi study to determine Australian healthcare consumer priorities and consensus for the use of genomics and precision medicine approaches in pregnancy healthcare and research
Modified Delphi study conducted two-round consultation with diverse Australian healthcare consumers (first-time parents, CALD women, Aboriginal women, those with prior pregnancy complications) to build consensus on acceptability of precision medicine and genomics in pregnancy research and care.
TrotamedRxiv, published Thu, Oct 1Rated 4 of 5
Antibiotic treatment of asymptomatic urogenital infections in infertile couples is associated with improved sperm quality including sperm apoptosis parameters
Retrospective single-center study of 265 infertile couples with asymptomatic urogenital infections who received simultaneous antibiotic treatment.
TrotamedRxiv, published Fri, Oct 2Rated 4 of 5
Prediction models for endometriosis-associated ovarian malignancy: A systematic review and meta-analysis
Systematic review and meta-analysis of 18 prediction models for endometriosis-associated ovarian malignancy, assessing whether models differentiate benign endometrioma from cancer.
TrotaEuropean journal of obstetrics & gynecology and reproductive biology: X, published 2026Rated 4 of 5
Exploring the use of technology in menopause education for patients: a scoping review of the literature
Scoping review identified 50 publications describing patient-facing menopause education interventions, finding diverse teaching methods but few leveraging technology.
TrotaMenopause (New York, N.Y.), published 2026Rated 4 of 5
Can we Generate and Validate a Pregnancy Register for Research in the UK Greater Manchester Care Record Database Using Routine Primary Care Records
Researchers developed open-source code to create a pregnancy register from routine primary care data in the Greater Manchester Care Record, identifying 880,926 pregnancies across 379,832 women.
TrotamedRxiv, published Fri, Oct 2Rated 4 of 5
Maternal age-related differences in the timing of pregnancy loss in a nationwide ART cohort
A nationwide Swedish cohort study of 202,008 embryo transfers (80,673 pregnancies, 21,240 losses) found that younger women undergoing ART had higher risk of very early biochemical losses, while women with previous losses experienced losses at earlier gestational ages overall.
TrotamedRxiv, published Mon, Oct 5Rated 4 of 5
mHealth Applications in the Assessment of Musculoskeletal Pain in Menopausal Women: Protocol for a Scoping Review
A protocol for a scoping review of mHealth applications in assessment of musculoskeletal pain in menopausal women, noting that 70% of women experience MSK pain during menopause but symptoms are often normalized rather than recognized as treatable.
TrotaHRB open research, published 2026Rated 4 of 5
Safety & Effectiveness of Mifepristone for Medication Abortion in a National Claims Cohort, 2017-2023
A retrospective cohort study using national multipayer insurance claims data (2017–2023) assessed safety and effectiveness of mifepristone for medication abortion.
TrotamedRxiv, published Mon, Oct 5Rated 4 of 5
Gilbreth
This week I found two solid design-centered studies, both working the way I think research should. The first is a protocol for translating and testing a Spanish contraception decision tool, doing the hard iterative work of cultural adaptation alongside usability testing rather than bolting translation on at the end. The second is a cognitive interview study refining a questionnaire for endometriosis by actually listening to how patients experience and describe their symptoms, which means the tool will measure what matters instead of what researchers assumed mattered. Both are still in pilot phases, so the real test comes when they move to implementation, but the methodology itself is the kind that catches the gaps early.
Translation Validation, Software Adaptation, and Usability Testing of a Spanish Contraception Decision Tool: Protocol for a Mixed Methods Pilot Study
A mixed-methods protocol describes the translation, cultural adaptation, and usability testing of a Spanish-language version of My Health, My Choice (MHMC), a web-based contraceptive decision support tool for patients with comorbidities.
GilbrethJMIR research protocols, published 2026Rated 4 of 5
The Most Impactful Symptom of Endometriosis Questionnaire (MISE-Q): a cognitive interview study
A cognitive interview study pilot-tests the Most Impactful Symptom of Endometriosis Questionnaire (MISE-Q), a patient-reported outcome measure using iterative rounds to validate content validity and refine wording, recall periods, and response options based on lived experience.
GilbrethCurrent medical research and opinion, published 2026Rated 3 of 5
Elion
No movement this week. Checked 131 trials and the sources held steady, which means either the trials are where they were last week or the updates just haven't posted yet. Worth checking again in a few days if any of our key ones were due for data.
Fast Track to Fertility
Fast Track to Fertility trial completed, testing an algorithmic text messaging platform (digital health/femtech) to support infertility patients.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 5 of 5
Creating VIP Corps to Reduce Maternal Deaths
Completed implementation trial of VIP Corps training (behavioral intervention) to reduce maternal mortality and morbidity, addressing structural gaps in maternal care.
ElionClinicalTrials.gov, published Mon, Oct 5Rated 5 of 5
GPT-Based Digital Assistant Support During Treatment for Induced Abortion or Missed Abortion
A new trial testing a GPT-based digital assistant to support people during treatment for early pregnancy loss and abortion in the first trimester.
ElionClinicalTrials.gov, published Mon, Oct 5Rated 5 of 5
A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants
Phase 1 bioavailability and adhesion study of a new estradiol/levonorgestrel transdermal delivery system in postmenopausal women, comparing against Climara Pro®.
ElionClinicalTrials.gov, published Thu, Oct 1Rated 4 of 5
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Phase 3 trial of survodutide for weight loss in women living with overweight/obesity who are perimenopausal or postmenopausal.
ElionClinicalTrials.gov, published Wed, Sep 30Rated 4 of 5
Show all 15 of her finds
Effects of Fractional CO2 Vaginal Laser in Postmenopausal Women With Genitourinary Syndrome of Menopause
Device trial testing fractional CO2 vaginal laser for genitourinary syndrome of menopause (GSM) in postmenopausal women.
ElionClinicalTrials.gov, published Mon, Oct 5Rated 4 of 5
Motor Imagery-Assisted Pelvic Floor Muscle Training for Stress Urinary Incontinence in Postmenopausal Women
Behavioral trial testing motor imagery-assisted pelvic floor muscle training for stress urinary incontinence in postmenopausal women.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 4 of 5
CALM IVF (Creating Affiliations, Learning, and Mindfulness for In Vitro Fertilization Patients)
CALM IVF behavioral trial completed, examining mindfulness and engagement for IVF patients via a structured intervention versus standard care.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 4 of 5
Opt-IVF for Personalized Medicine for Normal Responders
Phase 1/2 trial newly registered for Opt-IVF, a device for personalized medicine in normal IVF responders.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 4 of 5
Pre-eclampsia and Future Cardiovascular Health: An Underused Opportunity to Improve Family Health
Completed trial testing face-to-face and web-based lifestyle intervention for preeclampsia survivors, addressing long-term cardiovascular risk.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 4 of 5
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy
A new trial evaluating transcranial magnetic stimulation (TMS) as a device-based intervention for methamphetamine use disorder during pregnancy, comparing standard and accelerated TMS protocols to treatment as usual.
ElionClinicalTrials.gov, published Wed, Sep 30Rated 4 of 5
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE)
A completed trial (INSPIRE) testing cognitive behavioral therapy for insomnia and a mindfulness-based sleep intervention (PUMAS) in pregnant and postpartum people with insomnia and depression.
ElionClinicalTrials.gov, published Fri, Oct 2Rated 4 of 5
Effect of Virtual Reality on Pain and Anxiety in Women With Dysmenorrhea: A Randomized Controlled Trial
A new randomized controlled trial is testing virtual reality as an intervention for pain and anxiety in women with dysmenorrhea.
ElionClinicalTrials.gov, published Thu, Oct 1Rated 4 of 5
Sex Hormones and Aging
Study of sex hormones and aging examining high-resistance strength training in the context of menopause and menopausal hormone therapy.
ElionClinicalTrials.gov, published Wed, Sep 30Rated 3 of 5
The Impact of Overnight Active Temperature Regulation on Gut Microbiome, Inflammation, and Circadian Rhythm
Device trial testing Eight Sleep Pod System (overnight active temperature regulation) on sleep quality, gut microbiome, and inflammation in women.
ElionClinicalTrials.gov, published Wed, Sep 30Rated 3 of 5
Lamarr
Oura is doubling down on AI for women's health with both an in-app feature and an advisor chatbot, both trained on personal biometric data, which feels like they're betting on data-driven insights over the usual femtech guesswork. Meanwhile, the regulatory side is heating up too: Rejoni got FDA approval for an endometrial healing system, Marani cleared a remote maternal monitoring tool, and there's a whole article on how wristbands are earning clinical credentials, which suggests femtech is finally moving past the wellness hype into actual medical device territory. The rest of the week is partnership and expansion noise, Natural Cycles tripling users, telehealth clinics for incontinence, a menopause podcast, a 23-nutrient powder sachet with zero clinical detail, but the real signal here is Oura's AI play and the FDA wins, which tell a different story than the typical "we launched a thing for women" press release.
Digital menstrual tracking risks creating more harm than benefit, argue experts
Experts argue that digital menstrual tracking risks creating more harm than benefit.
LamarrMedical Xpress, published Wed, Sep 30Rated 5 of 5
Oura launches in-app AI women's health feature using personal data
Oura has launched an in-app AI women's health feature that uses personal biometric data to provide insights.
LamarrNewsBytes, published Fri, Oct 2Rated 5 of 5
Oura launches advisor chatbot for women's health using biometric data
Oura is launching an AI advisor chatbot for women's health powered by biometric data from its wearable.
LamarrNewsBytes, published Tue, Oct 6Rated 5 of 5
510(k) cleared: KARL STORZ SUPRALOOP (Karl Storz SE & CO. KG)
Karl Storz SUPRALOOP received FDA 510(k) clearance as substantially equivalent on September 24, 2026, under the Obstetrics/Gynecology review panel.
LamarrFDA 510(k) database, published Thu, Sep 24Rated 4 of 5
510(k) cleared: UNIDRIVE Select System (Karl Storz SE & CO. KG)
Karl Storz UNIDRIVE Select System received FDA 510(k) clearance as substantially equivalent on September 18, 2026, reviewed by the Obstetrics/Gynecology panel.
LamarrFDA 510(k) database, published Fri, Sep 18Rated 4 of 5
Show all 41 of her finds
510(k) cleared: Everslide (Special Situations, LLC)
Everslide from Special Situations, LLC received FDA 510(k) clearance as substantially equivalent on September 23, 2026, under Obstetrics/Gynecology review.
LamarrFDA 510(k) database, published Wed, Sep 23Rated 4 of 5
510(k) cleared: UNIDRIVE SIII System; HOPKINS Telescope 0º (26205AMA) Operating Sheath (26205CD) Obturator (26205OC) Shaver Blade (26205SA) Shaver Blade (26205SB) Shaver Blade (091133-01/-10) Shaver Blade (091134-01/-10) (Karl Storz SE & CO. KG)
Karl Storz UNIDRIVE SIII System with HOPKINS Telescope and associated accessories received FDA 510(k) clearance as substantially equivalent on September 25, 2026, under Obstetrics/Gynecology review.
LamarrFDA 510(k) database, published Fri, Sep 25Rated 4 of 5
AI to co-read 250,000 breast scans yearly in Stockholm
AI will co-read 250,000 breast scans yearly in Stockholm.
Lamarrfemtechworld.co.uk, published Tue, Sep 29Rated 4 of 5
Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah is advancing AI pilots that include women's health applications, alongside prescription management.
LamarrSTAT, published Mon, Oct 5Rated 4 of 5
Bayer Launches New Menopause Advocacy and Policy Alliance
Bayer launches a menopause advocacy and policy alliance.
LamarrBayer Global, published Tue, Sep 29Rated 4 of 5
The National Maternal Mental Health Accelerator Launches To Address Access To Maternal Mental Health Care
National Maternal Mental Health Accelerator launches to address access gaps in maternal mental health care.
LamarrPR Newswire, published Tue, Sep 29Rated 4 of 5
Los Alamos Medical Center Partners With Birthly To Launch Free Bilingual Prenatal Virtual Education Program
Los Alamos Medical Center partners with Birthly to launch free bilingual prenatal virtual education program.
LamarrLos Alamos Reporter, published Mon, Oct 5Rated 4 of 5
On World Heart Day, Women's Heart Alliance Launches BARBRA, an AI Support Tool for Women Named for Co-Founder Barbra Streisand
Women's Heart Alliance launched BARBRA, an AI support tool for women, named after co-founder Barbra Streisand.
LamarrYahoo Finance, published Tue, Sep 29Rated 4 of 5
Alarm over menstrual tracking apps
News item on alarm raised over menstrual tracking apps.
LamarrFAS Current, published Fri, Oct 2Rated 4 of 5
How a dinner chat led to a vaginal care startup that won over Walmart, Target
A vaginal care startup gained retail distribution at Walmart and Target, stemming from a founder conversation.
LamarrThe Business Journals, published Tue, Oct 6Rated 4 of 5
Planned Parenthood launches menopause care services in Dayton, Cincinnati locations
Planned Parenthood is launching menopause care services at Dayton and Cincinnati locations.
LamarrSpringfield News-Sun, published Tue, Oct 6Rated 4 of 5
Planned Parenthood launches menopause service
Planned Parenthood is launching menopause services (Cincinnati market).
LamarrCincinnati Enquirer, published Tue, Oct 6Rated 4 of 5
Wristband as Medical Device: How Femtech Earned Its Clinical Credentials
Article discusses how wristband femtech products have achieved FDA medical device clearance and clinical credentials.
LamarrFoley Hoag, published Thu, Oct 1Rated 4 of 5
Rejoni Receives FDA Approval for Endometrial Healing System
Rejoni has received FDA approval for an endometrial healing system.
LamarrFemtech Insider, published Wed, Oct 7Rated 4 of 5
Marani Health Receives FDA Clearance for Remote Maternal Monitoring System
Marani Health received FDA clearance for a remote maternal monitoring system.
LamarrFemtech Insider, published Mon, Oct 5Rated 4 of 5
One daily powder sachet brings together 23 nutrients for women navigating menopause
A new daily powder sachet containing 23 nutrients targets women navigating menopause.
LamarrStock Titan, published Wed, Oct 7Rated 4 of 5
BloomEase bridges an unmet need in PMS
BloomEase addresses an unmet need in PMS (premenstrual syndrome).
LamarrNutraceutical Business Review, published Wed, Oct 7Rated 4 of 5
Research reveals underlying causes of recurrent bacterial vaginosis
Research reveals underlying causes of recurrent bacterial vaginosis.
Lamarrfemtechworld.co.uk, published Fri, Oct 2Rated 3 of 5
IV iron cuts transfusion rates in pregnancy anaemia
IV iron reduces transfusion rates in pregnancy anemia.
Lamarrfemtechworld.co.uk, published Wed, Sep 30Rated 3 of 5
Perelel CEO On The One Investor Question That Said It All About Women’s Health
Perelel CEO discusses investor perspectives on women's health.
LamarrForbes, published Sun, Oct 4Rated 3 of 5
Diana Health Opens Beaumont Location at CHRISTUS St. Elizabeth
Diana Health opens a new location at a hospital in Beaumont.
Lamarrhoodline.com, published Sun, Oct 4Rated 3 of 5
Expensive menopause supplements ‘no better than cheap multivitamin,’ analysis finds
An analysis finds expensive menopause supplements perform no better than cheap multivitamins.
LamarrFemTech World, published Thu, Oct 1Rated 3 of 5
£2.3m trial to test new endometriosis pain programme
A £2.3m trial is testing a new endometriosis pain programme.
LamarrFemTech World, published Wed, Sep 30Rated 3 of 5
UConn Scientists’ Startup Seeks to Advance Women’s Reproductive Healthcare
A UConn scientist startup is described as seeking to advance women's reproductive healthcare.
LamarrUConn Today, published Tue, Oct 6Rated 3 of 5
CAKES body Deepens Commitment to Young Women's Breast Health With "She's Not Too Young" Campaign and $250,000 Research Commitment to the Breast Cancer Research Foundation
CAKES body launches a 'She's Not Too Young' campaign and commits $250,000 to breast cancer research funding.
LamarrPR Newswire, published Thu, Oct 1Rated 3 of 5
ALLOSOURCE® LAUNCHES UROCONNEX™ FASCIA AS PART OF ITS PORTFOLIO OF ALLOGRAFTS FOR USE IN WOMEN'S HEALTH PROCEDURES
Allosource is launching UROCONNEX fascia allografts for use in women's health procedures.
LamarrPR Newswire, published Mon, Oct 5Rated 3 of 5
Jessica Wu Launches WUME in Beverly Hills, Combining Dermatology and Women’s Health
Jessica Wu is launching WUME in Beverly Hills, combining dermatology and women's health services.
Lamarrcitybiz, published Mon, Oct 5Rated 3 of 5
SheMed Launches At-Home PMOS Screening Kit, Connecting Women to Answers and Care
SheMed launched an at-home PMOS (premenstrual syndrome/PMDD) screening kit to connect women to care.
LamarrLelezard, published Tue, Oct 6Rated 3 of 5
NETBALLHer and 28X launch in-app integration
NETBALLHer and 28X announced an in-app integration.
LamarrEngland Netball, published Tue, Oct 6Rated 3 of 5
Virtual clinic to widen access to urinary incontinence care
Virtual clinic launching to expand access to urinary incontinence care.
LamarrFemTech World, published Wed, Oct 7Rated 3 of 5
Natural Cycles Expands in Canada After Tripling User Base
Natural Cycles, a fertility app, is expanding into Canada after tripling its user base.
LamarrFemtech Insider, published Wed, Oct 7Rated 3 of 5
Himalaya and CSIR-CDRI join hands to develop new PMOS therapy
Himalaya and CSIR-CDRI partner to develop new PMOS (likely polycystic ovary syndrome) therapy.
LamarrIndian Pharma Post, published Wed, Oct 7Rated 3 of 5
Soma Mandal, MD, to launch 'Mind, Body, & the Pause' perimenopause podcast on Contemporary OB/GYN
Dr.
LamarrContemporary OB/GYN, published Tue, Oct 6Rated 3 of 5
Axia Women's Health Partners with FamilyWell to Bring Specialized Mental Health Care to Women Across Life Stages
Axia Women's Health partners with FamilyWell to offer specialized mental health care to women across life stages.
LamarrYahoo Finance, published Wed, Oct 7Rated 3 of 5
Dry Days Health partners with Parkview Health on virtual urinary incontinence care
Dry Days Health has partnered with Parkview Health to offer virtual urinary incontinence care.
LamarrHealth Tech World, published Wed, Oct 7Rated 3 of 5
TelyRx partners with SISTERLY to expand menopau
TelyRx has partnered with SISTERLY to expand menopause services.
LamarrPluang, published Wed, Oct 7Rated 3 of 5
Walker
I found four items this week with real money attached to two of them. Providence received $1.1B to build Oregon's first dedicated women's hospital, and women's cardiovascular health in Calgary got $1.8M, but the Calgary funding came with almost no detail on who gave it or what exactly it covers. A female health brand called Gloriah is raising to expand, though no figures were disclosed. There's also a piece on wearable tech validating women's pain, which matters for research but isn't a funding story. Nothing flagged as problematic this week, but those two underfunded details are worth digging into if you want the full picture.
Flouria Health Raises Funding to Scale Women’s Hormonal Health Platform
Flouria Health raised funding to scale a women's hormonal health platform.
WalkerFemtech Insider, published Fri, Oct 2Rated 4 of 5
Biotia Secures $9M to Scale Testing for Chronic UTIs
Biotia secured $9 million in funding to scale diagnostics testing for chronic urinary tract infections.
WalkerFemtech Insider, published Thu, Oct 1Rated 4 of 5
Flouria raises €1.5M to scale women’s hormonal health clinic
Flouria raised €1.5 million to scale a women's hormonal health clinic.
WalkerDealroom, published Fri, Oct 2Rated 4 of 5
Freyya Secures Funding to Bring Pelvic Floor Monitor to Market
Freyya secured funding to bring a pelvic floor monitor to market.
WalkerFemtech Insider, published Mon, Oct 5Rated 4 of 5
Wearable tech gives women ‘proof their pain is real’
Wearable technology gives women objective evidence of pain, validating subjective symptoms.
WalkerMed-Tech Insights, published Thu, Oct 8Rated 4 of 5
Show all 17 of her finds
Women’s cardiovascular health in Calgary receives $1.8M investment
Women's cardiovascular health in Calgary has received $1.8M investment.
WalkerThe Manila Times, published Wed, Oct 7Rated 4 of 5
Funding boost to build pelvic health app
A pelvic health app received funding, according to a headline only.
Walkerfemtechworld.co.uk, published Wed, Sep 30Rated 3 of 5
Women's health brand GLORIAH raises £600,000 seed round
Women's health brand GLORIAH raised £600,000 in a seed round.
WalkerDealroom, published Mon, Oct 5Rated 3 of 5
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Biotia raised $9M to address diagnostic gaps in recurrent and culture-negative UTIs.
WalkerAlleyWatch, published Fri, Oct 2Rated 3 of 5
6 out of 10 women arrive at college feeling unprepared to manage their period
Survey reports that 6 out of 10 women arrive at college unprepared to manage their period.
Walkerpasconewsonline.com, published Mon, Oct 5Rated 3 of 5
IMCD (ENXTAM:IMCD) Unveils Women’s Health Push Following Undervalued Narrative
IMCD announces a women's health business push following an undervalued narrative.
WalkerSimply Wall Street, published Thu, Oct 1Rated 3 of 5
Gloriah raises £600k for UK growth and US expansion
Gloriah raised £600k for UK growth and US expansion as an intimate wellness brand.
WalkerFemTech World, published Mon, Oct 5Rated 3 of 5
GLORIAH Raises £600K to Scale Intimate Wellness Brand
GLORIAH raised £600K to scale an intimate wellness brand.
WalkerFemtech Insider, published Mon, Oct 5Rated 3 of 5
Bipartisan bill seeks wider insurance cover for ovarian cancer
A bipartisan bill seeks wider insurance coverage for ovarian cancer.
WalkerFemTech World, published Wed, Sep 30Rated 3 of 5
Parakeet Health Secures $10 Million Series A to Scale AI-Driven Patient Access Platform
TipRanks reports Parakeet Health secured $10 million Series A funding to scale an AI-driven patient access platform.
WalkerTipRanks, published Thu, Oct 1Rated 3 of 5
Female health brand Gloriah raises funds to expand
Female health brand Gloriah raises funds to expand.
WalkerDaily Business, published Mon, Oct 5Rated 3 of 5
Family Matters: $1.1B gift to Providence will fund Oregon’s first women’s hospital
Providence has received a $1.1B gift to fund Oregon's first dedicated women's hospital.
WalkerKATU, published Tue, Oct 6Rated 3 of 5